Actavis plc (NYSE: ACT) today announced that it has launched a generic version of Celebrex® (celecoxib) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE